Search for: "Glaxo Wellcome Inc"
Results 1 - 20
of 26
Sorted by Relevance
|
Sort by Date
21 Feb 2013, 3:45 pm
Anyway, spotting a recent decision from the Patents Court, England and Wales, by the name of Glenmark Generics (Europe) Limited & others v The Wellcome Foundation Limited & and Glaxo Group Ltd [2013] EWHC 148 (Pat), his first thought was that it must have something to do with alcohol. [read post]
17 Feb 2018, 2:54 am
"The concerns noted by Lord Oliver in Reckitt & Colman Ltd v Borden Inc [1990] 1 All E.R. 873 have remained at the forefront of the judicial mind and whilst they have come in and out of vogue over the years, they are now accepted as a necessary evil in at least some circumstances.The survey question was recently considered in Glaxo Wellcome UK Ltd (t/a Allen & Hanburys) & Anor v Sandoz Ltd & Ors [2017] EWHC 3196 (Ch). [read post]
19 Jul 2010, 6:34 am
DB Investments Inc. [read post]
9 Jun 2009, 4:17 am
Glaxo Wellcome, Inc., No. 98 Civ. 6243, 2000 WL 1702028, at *1 (S.D.N.Y. [read post]
8 Apr 2010, 5:21 pm
" Burroughs Wellcome Co. v. [read post]
25 Feb 2014, 2:49 pm
And how truly valuable are pharmaceutical house marks such as Merck, Schering or GSK in an age in which the sector is so regulated, most purchases are surely made on bases other than whether a drug is made by one company or another, and in a sophisticated market in which consumers can understand when companies rebrand (did anyone get confused when Smith Kline and French, Beckman, Glaxo, Wellcome and Beecham evolved into GSK)? [read post]
26 Jan 2009, 12:47 am
That is a 29% premium over where the shares closed on Thursday before The Wall Street Journal reported that the two were in talks.With a value of $68 billion, the deal is the largest takeover in the pharmaceutical sector since Glaxo Wellcome PLC acquired SmithKline Beecham PLC for $76 billion in 2000.Wyeth Chief Executive Bernard J. [read post]
5 Aug 2010, 11:06 pm
It asserts that where the commercial product meets the claim limitations, a comparison to that product may be used to establish infringement, citing Glaxo Wellcome, Inc. v. [read post]
13 Sep 2009, 12:55 am
Shapira) indicating that court orders can override confidential information, even for financial records, and Glaxo-Wellcome PLC v. [read post]
13 Sep 2009, 1:02 am
Shapira) indicating that court orders can override confidential information, even for financial records, and Glaxo-Wellcome PLC v. [read post]
27 Aug 2018, 3:11 pm
Yes, we do have the pink stuff in the ceiling, the particular shade of green and yellow of agricultural implements which we hold dear, we also have the various conflicts regarding the colour purple for chocolate products, the colour purple for inhalers - Glaxo Wellcome v Sandoz [2017] EWHC 3196 here - the difficulty of how to represent the particular colour(s), the registrability of single colours and acquired distinctiveness etc (see the decision of the then European… [read post]
6 Mar 2014, 12:41 pm
Glaxo Wellcome PLC, 246 F.3d 934 (7th Cir. 2001). [read post]
23 Aug 2012, 12:47 pm
Glaxo Wellcome, Inc., 2005 WL 3440440, at *5-6 (D.N.J. [read post]
2 Feb 2010, 7:28 am
Glaxo Wellcome, Inc., 2005 WL 3440440, at *6 n.7 (D.N.J. [read post]
26 Jun 2007, 7:00 am
Glaxo Wellcome PLC, 246 F.3d 934, 942-43 (7th Cir. 2001).Where these laws govern, third parties have a tough time prevailing against drug and device companies on consumer fraud or deceptive trade practice claims. [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram) – US: Caraco… [read post]
5 Jul 2007, 10:37 am
Glaxo, Inc., 790 So.2d 35, 38 (La. [read post]
24 May 2007, 10:40 am
Vitek, Inc., 803 F. [read post]
28 Jun 2007, 10:16 am
Pfizer, Inc., ___ F. [read post]
21 Oct 2014, 12:00 am
In Glenmark Generics (Europe) Limited & others v The Wellcome Foundation Limited & Glaxo Group Ltd, [2013] EWHC 148 (Pat), reported by the IPKat here, Arnold J decided that a combination product for treating malaria was obvious. [read post]
